Updated Jul 16, 2026
Deshpande Milind has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Deshpande Milind is an individual connected to Spero Therapeutics, Inc. via SEC filings as of the 2026-06-25 filing date. Public biographical information for this person is limited in widely available sources. In corporate SEC records, he is listed in connection with Spero Therapeutics; the exact current role is not explicitly stated in the provided context. No widely reported public biography or detailed personal background is readily verifiable from standard public sources. He may be an executive, director, or other insider at the company depending on the specific filing; without the exact document, the precise title cannot be confirmed.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-25 | SPRO | Spero Therapeutics, Inc. | A — Grant or award | 10.0K | $0.00 |
Deshpande Milind is an individual connected to Spero Therapeutics, Inc. via SEC filings as of the 2026-06-25 filing date. Public biographical information for this person is limited in widely available sources. In corporate SEC records, he is listed in connection with Spero Therapeutics; the exact current role is not explicitly stated in the provided context. No widely reported …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Deshpande Milind profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.